United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution is contraindicated in the following conditions: -   gastrointestinal (gi) obstruction [see warnings and precautions (5.6)] -   bowel perforation [see warnings and precautions (5.6)] -   gastric retention -   ileus -   toxic colitis or toxic megacolon -   hypersensitivity to any ingredient in peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution [see warnings and precautions (5.10)] risk summary there are no available data on peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution in pregnant women to inform a drug-associated risk for adverse developmental

Canada - English - Health Canada

nissan chemical industries ltd. - ascorbic acid (ascorbic acid, sodium ascorbate) - stick - 300mg - ascorbic acid (ascorbic acid, sodium ascorbate) 300mg - vitamin c

United States - English - NLM (National Library of Medicine)

flon laboratories llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febril states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid

United States - English - NLM (National Library of Medicine)

raw materials international overseas llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid.

United States - English - NLM (National Library of Medicine)

vertical pharmaceuticals inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), sodium ascorbate (unii: s033eh8359) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyrid - ascorbic acid 50 mg - ob complete™ chewable is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - ascorbic acid as sodium ascorbate - unknown - ascorbic acid as sodium ascorbate vitamin-c active 0.0 - active constituent

Philippines - English - FDA (Food And Drug Administration)

metz pharmaceuticals, inc. - ascorbic acid , cholecalciferol , zinc - capsule classification: over-the-counter (otc) - 500 mg (equivalent to 562.43 mg sodium ascorbate) 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate) dosage

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: n/a; distributor: n/a - ascorbic acid (as sodium ascorbate) - capsule - formulation: each 500 mg capsule contains: ascorbic acid (equivalent to 562 mg sodium ascorbate) 500 mg

United States - English - NLM (National Library of Medicine)

deremetrx llc - sodium ascorbate (unii: s033eh8359) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), tocophersolan (unii: o03s90u1f2) (tocophersolan - unii:o03s90u1f2), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: - sodium ascorbate 120 mg - indications and usage:  pre-tabs dha is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation to women throughout pregnancy, during the postnatal for both lactating and nonlactating mothers. pre-tabs dha is also beneficial in improving the nutritional status of women prior to conception. contraindications: this product is contraindicated in patients with a known hypersensitivity to any of the ingredients .

United States - English - NLM (National Library of Medicine)

salix pharmaceuticals, inc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - plenvu® is indicated for cleansing of the colon in preparation for colonoscopy in adults. plenvu is contraindicated in the following conditions: risk summary there are no available data with plenvu in pregnant women to inform a drug-associated risk for adverse developmental outcomes. animal reproduction studies have not been conducted with plenvu. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary there are no data available to assess the presence of plenvu in human milk, the effects on the breastfed child or the effects on milk production. the lack of clinical data during lactation precludes a clear determination of the risk of plenvu to a child during lactation; therefore